The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients

The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients

Canine cancer rates are similar to humans, though the therapeutic options might be limited. Inducing a patient’s own immune system to have an anti-tumor response is an attractive approach to cancer therapy. In this safety study, autologous tumor vaccines produced specifically for each cani...

Full description

Bibliographic Details
Main Authors: Chris Weir, Annika Oksa, Jennifer Millar, Miles Alexander, Nicola Kynoch, Zoe Walton-Weitz, Peter Mackenzie-Wood, Felicia Tam, Hope Richards, Richard Naylor, Katrina Cheng, Peter Bennett, Nikolai Petrovsky, Rachel Allavena
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Veterinary Sciences
Subjects:
vaccine
autologous
canine
adjuvant
Advax™
Online Access:http://www.mdpi.com/2306-7381/5/4/87

Internet

http://www.mdpi.com/2306-7381/5/4/87

Similar Items